MedPath

Prcl Research Inc.

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website

A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

Phase 2
Completed
Conditions
Plaque Psoriasis
Psoriasis Vulgaris
Interventions
Drug: Placebo
First Posted Date
2018-08-03
Last Posted Date
2020-03-30
Lead Sponsor
PRCL Research Inc.
Target Recruit Count
92
Registration Number
NCT03614078
Locations
🇨🇦

Lynderm Research Inc., Markham, Ontario, Canada

🇸🇰

SKINKLINIK Dermatovenerologická ambulancia, Bratislava, Slovakia

🇨🇦

Carey-Wang - Dermatology & Dermatologic Surgery Center, Westmount, Quebec, Canada

and more 13 locations

A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis

Phase 1
Completed
Conditions
Psoriasis
Interventions
Drug: Placebo Oral Tablet
First Posted Date
2017-02-23
Last Posted Date
2018-03-07
Lead Sponsor
PRCL Research Inc.
Target Recruit Count
50
Registration Number
NCT03062618
Locations
🇨🇦

Dr. Chih-ho Hong Medical Inc, Surrey, British Columbia, Canada

🇨🇦

Lynde Centre for Dermatology, Markham, Ontario, Canada

🇨🇦

Centre de Dermatologie et Chirurgie Dermatologique, Montreal, Quebec, Canada

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath